AU2002223470A1 - Modulation of the transcription of pro-inflammatory gene products - Google Patents
Modulation of the transcription of pro-inflammatory gene productsInfo
- Publication number
- AU2002223470A1 AU2002223470A1 AU2002223470A AU2002223470A AU2002223470A1 AU 2002223470 A1 AU2002223470 A1 AU 2002223470A1 AU 2002223470 A AU2002223470 A AU 2002223470A AU 2002223470 A AU2002223470 A AU 2002223470A AU 2002223470 A1 AU2002223470 A1 AU 2002223470A1
- Authority
- AU
- Australia
- Prior art keywords
- transcription
- pro
- modulation
- gene products
- inflammatory gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000051 modifying Effects 0.000 title 1
- 230000000770 pro-inflamatory Effects 0.000 title 1
- 230000035897 transcription Effects 0.000 title 1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10049549A DE10049549A1 (en) | 2000-10-06 | 2000-10-06 | Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40 |
DE10049549.4 | 2000-10-06 | ||
DE10059144A DE10059144A1 (en) | 2000-10-06 | 2000-11-29 | Modulation of the transcription of pro-inflammatory gene products |
DE10059144.2 | 2000-11-29 | ||
PCT/DE2001/003835 WO2002029044A2 (en) | 2000-10-06 | 2001-10-04 | Modulation of the transcription of pro-inflammatory gene products |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002223470A1 true AU2002223470A1 (en) | 2002-06-27 |
AU2002223470B2 AU2002223470B2 (en) | 2007-01-04 |
Family
ID=26007280
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002223470A Ceased AU2002223470B2 (en) | 2000-10-06 | 2001-10-04 | Modulation of the transcription of pro-inflammatory gene products |
AU2347002A Pending AU2347002A (en) | 2000-10-06 | 2001-10-04 | Modulation of the transcription of pro-inflammatory gene products |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2347002A Pending AU2347002A (en) | 2000-10-06 | 2001-10-04 | Modulation of the transcription of pro-inflammatory gene products |
Country Status (11)
Country | Link |
---|---|
US (2) | US7524949B2 (en) |
EP (1) | EP1325122A2 (en) |
JP (1) | JP2004510787A (en) |
CN (1) | CN100436578C (en) |
AU (2) | AU2002223470B2 (en) |
CA (1) | CA2424604A1 (en) |
DE (2) | DE10049549A1 (en) |
NO (1) | NO20031408D0 (en) |
PL (1) | PL362987A1 (en) |
RU (1) | RU2003107669A (en) |
WO (1) | WO2002029044A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2307733T3 (en) * | 2001-02-20 | 2008-12-01 | Anges Mg, Inc. | TOPICAL USE OF NF-KB LURE COMPOUNDS TO TREAT ATOPIC DERMATITIS. |
DE10148828B4 (en) * | 2001-10-04 | 2005-05-19 | Avontec Gmbh | Modulation of the expression of STAT-1-dependent genes |
WO2003061386A1 (en) * | 2002-01-03 | 2003-07-31 | Board Of Regents, The University Of Texas System | Wt1 antisense oligos for the inhibition of breast cancer |
DE10240417A1 (en) * | 2002-09-02 | 2004-03-11 | Avontec Gmbh | Decoy oligonucleotide inhibition of CD40 expression |
JP2007512847A (en) * | 2003-12-03 | 2007-05-24 | アネシヴァ, インコーポレイテッド | HIF oligonucleotide decoy molecule |
SI2158316T1 (en) | 2007-05-11 | 2015-08-31 | Adynxx Inc. | Gene expression and pain |
EP2440566A4 (en) * | 2009-06-08 | 2013-10-16 | Miragen Therapeutics | CHEMICAL MODIFICATION MOTIFS FOR miRNA INHIBITORS AND MIMETICS |
ES2724851T3 (en) | 2012-05-10 | 2019-09-16 | Adynxx Inc | Formulations for the supply of active ingredients |
WO2015095636A2 (en) * | 2013-12-19 | 2015-06-25 | The Children's Hospital Of Philadelphia | Interferon regulatory factor 1 (irf1) decoys and methods of use thereof |
CN103751804B (en) * | 2014-01-23 | 2015-09-30 | 武汉大学 | The application of interferon regulatory factor 4 (IRF4) gene in coronary atherosclerotic heart disease |
EP3626822A1 (en) | 2014-08-15 | 2020-03-25 | Adynxx, Inc. | Oligonucleotide decoys for the treatment of pain |
CN104258419A (en) * | 2014-09-29 | 2015-01-07 | 武汉大学 | Applications of interferon regulatory factor 1 gene in treatment of atherosclerosis |
EP3244790B1 (en) * | 2015-01-15 | 2020-09-02 | Koninklijke Philips N.V. | Instantaneous wave-free ratio (ifr) computer tomography (ct) |
CN106620719A (en) * | 2016-10-20 | 2017-05-10 | 武汉大学 | IRF1 (interferon regulatory factor 1) as well as function and application of inhibitor of IRF1 in treatment of fatty liver and type-II diabetes |
WO2020101880A1 (en) * | 2018-11-14 | 2020-05-22 | Oklahoma Medical Research Foundation | Compositions and methods of treating systemic lupus erythematosus |
AU2019403057A1 (en) * | 2018-12-16 | 2021-07-29 | Figene, Llc | Therapeutic uses of gene edited fibroblasts |
CN114948965B (en) * | 2022-07-18 | 2023-11-10 | 四川大学华西第二医院 | Application of compound in preparation of medicine for preventing and treating tissue injury |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3847366B2 (en) | 1996-02-22 | 2006-11-22 | アンジェスMg株式会社 | Stationary mitotic cell growth agent using antisense oligonucleotide |
US6060310A (en) * | 1997-11-24 | 2000-05-09 | The United States Of America As Represented By The Department Of Health And Human Services | Transcription factor decoy and tumor growth inhibitor |
EP1100963A2 (en) * | 1998-07-25 | 2001-05-23 | AstraZeneca AB | Human ccr-2 gene polymorphisms |
CN1317009A (en) * | 1998-08-03 | 2001-10-10 | 东卡罗来纳大学 | Low adenosine anti-sense oligonucleotide agent, composition, reagent kit and treatments |
AU2750800A (en) * | 1999-02-01 | 2000-08-18 | Amgen Canada Inc. | Materials and methods to inhibit hodgkin and reed sternberg cell growth |
IL140054A0 (en) * | 1999-04-06 | 2002-02-10 | Univ East Carolina | Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy (ies) and surfactant depletion |
AU4232700A (en) * | 1999-04-12 | 2000-11-14 | Ribozyme Pharmaceuticals, Inc. | Regulation of repressor genes using nucleic acid molecules |
-
2000
- 2000-10-06 DE DE10049549A patent/DE10049549A1/en not_active Withdrawn
- 2000-11-29 DE DE10059144A patent/DE10059144A1/en not_active Withdrawn
-
2001
- 2001-10-04 AU AU2002223470A patent/AU2002223470B2/en not_active Ceased
- 2001-10-04 CN CNB018169465A patent/CN100436578C/en not_active Expired - Fee Related
- 2001-10-04 RU RU2003107669/13A patent/RU2003107669A/en not_active Application Discontinuation
- 2001-10-04 PL PL01362987A patent/PL362987A1/en unknown
- 2001-10-04 CA CA002424604A patent/CA2424604A1/en not_active Withdrawn
- 2001-10-04 AU AU2347002A patent/AU2347002A/en active Pending
- 2001-10-04 EP EP01986318A patent/EP1325122A2/en not_active Withdrawn
- 2001-10-04 WO PCT/DE2001/003835 patent/WO2002029044A2/en active Application Filing
- 2001-10-04 US US10/398,592 patent/US7524949B2/en not_active Expired - Fee Related
- 2001-10-04 JP JP2002532614A patent/JP2004510787A/en not_active Withdrawn
-
2003
- 2003-03-27 NO NO20031408A patent/NO20031408D0/en unknown
-
2009
- 2009-03-26 US US12/411,926 patent/US20090221686A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002223470A1 (en) | Modulation of the transcription of pro-inflammatory gene products | |
AU2347002A (en) | Modulation of the transcription of pro-inflammatory gene products | |
AU2002227172A1 (en) | Haplotypes of the cer1 gene | |
AU2001259595A1 (en) | Haplotypes of the crybb1 gene | |
AU2001290603A1 (en) | Haplotypes of the or11a1 gene | |
AU2001253101A1 (en) | Haplotypes of the scn2b gene | |
AU2001255330A1 (en) | Haplotypes of the akr1b1 gene | |
AU2001255402A1 (en) | Haplotypes of the npr1 gene | |
AU2001253431A1 (en) | Haplotypes of the f9 gene | |
AU2001266759A1 (en) | Haplotypes of the acp2 gene | |
AU2002245073A1 (en) | Haplotypes of the f2rli gene | |
AU2001249650A1 (en) | Haplotypes of the chrnb3 gene | |
AU2001274995A1 (en) | Haplotypes of the rlbp1 gene | |
AU2002213185A1 (en) | Haplotypes of the chrm5 gene | |
AU2001273117A1 (en) | Haplotypes of the appbp1 gene | |
AU2001286644A1 (en) | Haplotypes of the gng7 gene | |
AU2002227177A1 (en) | Haplotypes of the scya21 gene | |
AU2001292815A1 (en) | Haplotypes of the scya8 gene | |
AU2001288423A1 (en) | Haplotypes of the bmpr2 gene | |
AU2001296510A1 (en) | Haplotypes of the admr gene | |
AU2002228727A1 (en) | Haplotypes of the chrm4 gene | |
AU2001288422A1 (en) | Haplotypes of the lipg gene | |
AU2001255404A1 (en) | Haplotypes of the dnal4 gene | |
AU2001290557A1 (en) | Haplotypes of the il1rl1lg gene | |
AU2002211478A1 (en) | Haplotypes of the scyb14 gene |